AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC
AstraZeneca and Daiichi Sankyo have secured approval from the US Food and Drug Administration (FDA) for Datroway (datopotamab deruxtecan) to …
Post
-
-
Q&A: How 3PLs are navigating the latest pharma trends
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same …
-
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati
One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm …
-
Accelerate post-approval research by streamlining the entire study lifecycle
As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines. …
-
European STI cases reach record high amid testing and prevention gaps
New data debuted by the Europe’s infectious disease agency has revealed that cases of certain bacterial sexually transmitted infections (STIs) …
-
Q&A: How 3PLs are navigating the latest pharma trends
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same …
-
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati
One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm …
-
Accelerate post-approval research by streamlining the entire study lifecycle
As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines. …
-
European STI cases reach record high amid testing and prevention gaps
New data debuted by the Europe’s infectious disease agency has revealed that cases of certain bacterial sexually transmitted infections (STIs) …
-
Gilead Sciences completes Tubulis acquisition for $5bn
Gilead Sciences has concluded its acquisition of Tubulis, a Germany-based biotechnology company developing next-generation antibody-drug conjugates (ADCs), in a transaction …
-
Concept Life Sciences and OpenBench partner on drug discovery services
Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech …
-
Gilead teams up with WHO again to eliminate parasitic tropical disease
Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part …
-
Eli Lilly maintains M&A streak with $202m Engage Bio buyout
Pharmaceutical giant Eli Lilly has agreed to acquire Engage Biologics for up to $202m in cash, marking another addition to …
-
FUJIFILM opens new iPSC facility in Madison, US
FUJIFILM Cellular Dynamics has opened a new headquarters and induced pluripotent stem cell (iPSC) manufacturing facility in Madison, Wisconsin, US. The …
-
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
With pharma and medtech Q1 earnings season now at a close, some sector areas performed better than others. In this episode, …
